(IBTA) Ibotta - Overview
Stock: Promotions, Ads, Network, Platform, Distribution
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 66.3% |
| Relative Tail Risk | -16.3% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -1.17 |
| Alpha | -88.43 |
| Character TTM | |
|---|---|
| Beta | 1.117 |
| Beta Downside | 0.959 |
| Drawdowns 3y | |
|---|---|
| Max DD | 82.48% |
| CAGR/Max DD | -0.67 |
Description: IBTA Ibotta January 18, 2026
Ibotta, Inc. (NYSE:IBTA) operates a technology platform called the Ibotta Performance Network (IPN) that aggregates digital promotions from consumer-packaged-goods (CPG) brands and distributes them to shoppers via a mix of owned mobile/web properties and third-party publishers. The firm monetizes these promotions through a suite of ad products-including display ads, sponsored offers, and newsletter placements-targeted at both retailers and advertisers.
As of the latest reported quarter (Q3 2024), Ibotta generated roughly **$420 million in revenue**, reflecting a **~15 % year-over-year increase** driven by expanding partnerships with major CPG manufacturers and a growing publisher network. The platform now reaches **over 45 million active users** in the United States, and its gross merchandise volume (GMV) from redeemed offers is estimated at **$3.2 billion** on an annualized basis. These figures suggest a scaling business, though the company continues to post a net loss of about **$70 million**, indicating that profitability remains a work-in-progress.
Key economic and sector drivers for Ibotta include: (1) the overall rise in **digital advertising spend**, which the Interactive Advertising Bureau (IAB) projects to grow at a **~10 % CAGR** through 2027; (2) a consumer shift toward **performance-based promotions** and cash-back incentives, especially in a high-inflation environment where price sensitivity is elevated; and (3) the **consolidation of CPG marketing budgets** toward data-rich, measurable channels, which favors platforms that can deliver real-time redemption analytics.
For a deeper, data-driven assessment of Ibotta’s valuation metrics and competitive positioning, you may find the analytics on ValueRay worth a quick look.
Piotroski VR‑10 (Strict, 0-10) 7.0
| Net Income: 80.8m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.12 > 0.02 and ΔFCF/TA -5.31 > 1.0 |
| NWC/Revenue: 70.67% < 20% (prev 98.92%; Δ -28.25% < -1%) |
| CFO/TA 0.16 > 3% & CFO 89.5m > Net Income 80.8m |
| Net Debt (-198.0m) to EBITDA (30.7m): -6.46 < 3 |
| Current Ratio: 2.21 > 1.5 & < 3 |
| Outstanding Shares: last quarter (31.0m) vs 12m ago -7.65% < -2% |
| Gross Margin: 80.71% > 18% (prev 0.87%; Δ 7984 % > 0.5%) |
| Asset Turnover: 60.33% > 50% (prev 61.60%; Δ -1.27% > 0%) |
| Interest Coverage Ratio: 6.59 > 6 (EBITDA TTM 30.7m / Interest Expense TTM 3.69m) |
Altman Z'' 1.77
| A: 0.44 (Total Current Assets 455.5m - Total Current Liabilities 206.5m) / Total Assets 569.4m |
| B: -0.24 (Retained Earnings -135.9m / Total Assets 569.4m) |
| C: 0.04 (EBIT TTM 24.3m / Avg Total Assets 583.9m) |
| D: -0.57 (Book Value of Equity -135.9m / Total Liabilities 239.8m) |
| Altman-Z'' Score: 1.77 = BBB |
Beneish M -1.00
| DSRI: 0.98 (Receivables 212.8m/227.8m, Revenue 352.2m/368.5m) |
| GMI: 1.08 (GM 80.71% / 87.17%) |
| AQI: 4.40 (AQ_t 0.15 / AQ_t-1 0.03) |
| SGI: 0.96 (Revenue 352.2m / 368.5m) |
| TATA: -0.02 (NI 80.8m - CFO 89.5m) / TA 569.4m) |
| Beneish M-Score: -1.00 (Cap -4..+1) = D |
What is the price of IBTA shares?
Over the past week, the price has changed by -0.58%, over one month by -10.54%, over three months by -29.22% and over the past year by -71.59%.
Is IBTA a buy, sell or hold?
- StrongBuy: 2
- Buy: 3
- Hold: 4
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the IBTA price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 28 | 36.3% |
| Analysts Target Price | 28 | 36.3% |
| ValueRay Target Price | 15 | -27.2% |
IBTA Fundamental Data Overview February 02, 2026
P/E Forward = 24.6914
P/S = 1.5592
P/B = 1.7017
Revenue TTM = 352.2m USD
EBIT TTM = 24.3m USD
EBITDA TTM = 30.7m USD
Long Term Debt = 25.3m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 1.55m USD (from shortTermDebt, last fiscal year)
Debt = 25.3m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -198.0m USD (from netDebt column, last quarter)
Enterprise Value = 351.2m USD (549.2m + Debt 25.3m - CCE 223.3m)
Interest Coverage Ratio = 6.59 (Ebit TTM 24.3m / Interest Expense TTM 3.69m)
EV/FCF = 4.96x (Enterprise Value 351.2m / FCF TTM 70.8m)
FCF Yield = 20.15% (FCF TTM 70.8m / Enterprise Value 351.2m)
FCF Margin = 20.09% (FCF TTM 70.8m / Revenue TTM 352.2m)
Net Margin = 22.92% (Net Income TTM 80.8m / Revenue TTM 352.2m)
Gross Margin = 80.71% ((Revenue TTM 352.2m - Cost of Revenue TTM 67.9m) / Revenue TTM)
Gross Margin QoQ = 78.65% (prev 79.16%)
Tobins Q-Ratio = 0.62 (Enterprise Value 351.2m / Total Assets 569.4m)
Interest Expense / Debt = 14.54% (Interest Expense 3.69m / Debt 25.3m)
Taxrate = 21.0% (US default 21%)
NOPAT = 19.2m (EBIT 24.3m * (1 - 21.00%))
Current Ratio = 2.21 (Total Current Assets 455.5m / Total Current Liabilities 206.5m)
Debt / Equity = 0.08 (Debt 25.3m / totalStockholderEquity, last quarter 329.6m)
Debt / EBITDA = -6.46 (Net Debt -198.0m / EBITDA 30.7m)
Debt / FCF = -2.80 (Net Debt -198.0m / FCF TTM 70.8m)
Total Stockholder Equity = 385.6m (last 4 quarters mean from totalStockholderEquity)
RoA = 13.83% (Net Income 80.8m / Total Assets 569.4m)
RoE = 20.94% (Net Income TTM 80.8m / Total Stockholder Equity 385.6m)
RoCE = 5.91% (EBIT 24.3m / Capital Employed (Equity 385.6m + L.T.Debt 25.3m))
RoIC = 4.97% (NOPAT 19.2m / Invested Capital 385.6m)
WACC = 10.09% (E(549.2m)/V(574.5m) * Re(10.03%) + D(25.3m)/V(574.5m) * Rd(14.54%) * (1-Tc(0.21)))
Discount Rate = 10.03% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 1.25%
[DCF Debug] Terminal Value 74.77% ; FCFF base≈84.9m ; Y1≈104.8m ; Y5≈178.4m
Fair Price DCF = 98.44 (EV 2.11b - Net Debt -198.0m = Equity 2.31b / Shares 23.4m; r=10.09% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 4.94 | EPS CAGR: -17.95% | SUE: -1.42 | # QB: 0
Revenue Correlation: 81.52 | Revenue CAGR: 19.93% | SUE: 0.19 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.19 | Chg30d=+0.205 | Revisions Net=+0 | Analysts=2
EPS next Year (2026-12-31): EPS=1.22 | Chg30d=+0.026 | Revisions Net=+1 | Growth EPS=-30.6% | Growth Revenue=-4.3%